Cargando…

International multicenter examination of MOG antibody assays

OBJECTIVE: To compare the reproducibility of 11 antibody assays for immunoglobulin (Ig) G and IgM myelin oligodendrocyte glycoprotein antibodies (MOG-IgG and MOG-IgM) from 5 international centers. METHODS: The following samples were analyzed: MOG-IgG clearly positive sera (n = 39), MOG-IgG low posit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reindl, Markus, Schanda, Kathrin, Woodhall, Mark, Tea, Fiona, Ramanathan, Sudarshini, Sagen, Jessica, Fryer, James P., Mills, John, Teegen, Bianca, Mindorf, Swantje, Ritter, Nora, Krummrei, Ulrike, Stöcker, Winfried, Eggert, Juliane, Flanagan, Eoin P., Ramberger, Melanie, Hegen, Harald, Rostasy, Kevin, Berger, Thomas, Leite, Maria Isabel, Palace, Jacqueline, Irani, Sarosh R., Dale, Russell C., Probst, Christian, Probst, Monika, Brilot, Fabienne, Pittock, Sean J., Waters, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051197/ https://www.ncbi.nlm.nih.gov/pubmed/32024795 http://dx.doi.org/10.1212/NXI.0000000000000674

Ejemplares similares

Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases
por: Schanda, Kathrin, et al.
Publicado: (2021)

A multicenter comparison of MOG-IgG cell-based assays
por: Waters, Patrick J., et al.
Publicado: (2019)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
por: Pace, Samuel, et al.
Publicado: (2022)

MOG antibody-associated diseases
por: Reindl, Markus, et al.
Publicado: (2015)

Recent developments in MOG-IgG associated neurological disorders
por: Hegen, Harald, et al.
Publicado: (2020)

Humoral signatures of MOG-antibody-associated disease track with age and disease activity
por: Spatola, Marianna, et al.
Publicado: (2023)

Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders
por: Rinaldi, Simon, et al.
Publicado: (2020)

Seroprevalence and clinical phenotype of MOG-IgG-associated disorders in Sri Lanka
por: Senanayake, Bimsara, et al.
Publicado: (2019)

Serum MOG IgG titres should be performed routinely in the diagnosis and follow-up of MOGAD: Yes
por: Reindl, Markus, et al.
Publicado: (2023)

Failure of alemtuzumab therapy in three patients with MOG antibody associated disease
por: Seneviratne, Sinali O., et al.
Publicado: (2022)

Anti-NMDA receptor encephalitis and MOG-associated demyelination – a case report with long-term follow-up and a systematic review
por: Berek, Klaus, et al.
Publicado: (2022)

B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination
por: Kothur, Kavitha, et al.
Publicado: (2016)

GABA(A) receptor autoimmunity: A multicenter experience
por: O'Connor, Kevin, et al.
Publicado: (2019)

Autoantibodies against glutamate receptor δ2 after allogenic stem cell transplantation
por: Miske, Ramona, et al.
Publicado: (2016)

Effects of the Positive Threshold and Data Analysis on Human MOG Antibody Detection by Live Flow Cytometry
por: Tea, Fiona, et al.
Publicado: (2020)

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
por: Waters, Patrick, et al.
Publicado: (2015)

Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis
por: Hyun, Jae-Won, et al.
Publicado: (2018)

Comparison of Diagnostic Accuracy of Microscopy and Flow Cytometry in Evaluating N-Methyl-D-Aspartate Receptor Antibodies in Serum Using a Live Cell-Based Assay
por: Ramberger, Melanie, et al.
Publicado: (2015)

MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
por: Wildemann, Brigitte, et al.
Publicado: (2020)

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies
por: Lang, Bethan, et al.
Publicado: (2017)

Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton
por: Dale, Russell C., et al.
Publicado: (2014)

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
por: Ramanathan, Sudarshini, et al.
Publicado: (2018)

Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases
por: Hofer, Livia Sophie, et al.
Publicado: (2020)

NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases
por: Ramberger, Melanie, et al.
Publicado: (2015)

Editorial on EJPN focus section on E.U. paediatric MOG consortium consensus statements
por: Neuteboom, R.F., et al.
Publicado: (2020)

Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies
por: Wegener-Panzer, Andreas, et al.
Publicado: (2020)

The autoantibody-mediated encephalitides: from clinical observations to molecular pathogenesis
por: Ramanathan, Sudarshini, et al.
Publicado: (2019)

Randomized Placebo‐Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
por: Dubey, Divyanshu, et al.
Publicado: (2019)

Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome
por: Wendel, Eva Maria, et al.
Publicado: (2022)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
por: Kim, Sung-Min, et al.
Publicado: (2015)

Methodological Challenges in Protein Microarray and Immunohistochemistry for the Discovery of Novel Autoantibodies in Paediatric Acute Disseminated Encephalomyelitis
por: Peschl, Patrick, et al.
Publicado: (2017)

More Efficient Complement Activation by Anti–Aquaporin-4 Compared With Anti–Myelin Oligodendrocyte Glycoprotein Antibodies
por: Lerch, Magdalena, et al.
Publicado: (2022)

No strong HLA association with MOG antibody disease in the UK population
por: Grant‐Peters, Melissa, et al.
Publicado: (2021)

Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica
por: Wilson, Robert, et al.
Publicado: (2018)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
por: Jurynczyk, Maciej, et al.
Publicado: (2017)

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
por: Jarius, Sven, et al.
Publicado: (2020)

A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies
por: Morris, Katrina A., et al.
Publicado: (2015)

Predictors of relapse in MOG antibody associated disease: a cohort study
por: Huda, Saif, et al.
Publicado: (2021)

Epidemiology of Pediatric NMOSD in Germany and Austria
por: Lechner, Christian, et al.
Publicado: (2020)

MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome
por: Mariotto, Sara, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rhas6tkrld92kv6tspi35oevu0